Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01864525 · ClinicalTrials.gov registry record · Phase 1
Effects of Octanoic Acid for Treatment of Essential Voice Tremor
A Phase 1 study, sponsored by Syracuse University.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT01864525 is a Phase 1 study that has completed, run by Syracuse University. The registered enrollment target is 17 participants.
The verdict
NCT01864525, a Phase 1 study, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
Essential voice tremor is a neurological condition that produces a regular, shaking quality in the voice. One form of drug treatment that produces some improvement in tremor of the hands is octanoic acid, which is a food additive that is similar to alcohol. Research suggests that octanoic acid may reduce tremor in the hands/arms with few side effects and no intoxication effects. This study will determine whether octanoic acid may be useful for reducing tremor when it affects the voice. Researchers are hypothesizing that octanoic acid will reduce the effects of tremor on the voice.
Interventions
- DRUG Octanoic acid
- DRUG Inactive capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-07 |
| Est. Completion | 2017-03-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01864525
The ClinicalTrials.gov registry entry for NCT01864525 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syracuse University, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Octanoic acid is the first listed.
NCT01864525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01864525 about?
NCT01864525 is a clinical study titled "Effects of Octanoic Acid for Treatment of Essential Voice Tremor". Essential voice tremor is a neurological condition that produces a regular, shaking quality in the voice. One form of drug treatment that produces some improvement in tremor of the hands is octanoic acid, which is a food additive that is similar to alcohol. Research suggests that octanoic acid may r...
What is the current status of trial NCT01864525?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2013-07. Estimated completion is 2017-03-31.
What interventions are being tested in trial NCT01864525?
The interventions under investigation include: Octanoic acid (DRUG), Inactive capsule (DRUG).
Who is sponsoring clinical trial NCT01864525?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.